drugset / Trial / NCT00213759

Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF

NCT00213759 ↗

Phase 3 Completed 200 enrolled University Hospital, Strasbourg, France
RandomizedParallel-groupTriple-blindPrevention

Summary

Prevention trial of nosocomial infections in neutropenic prematures with G-CSF

Timeline

Start
2002-03
Primary completion
—
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator filgrastim Protein / enzyme biologic 10 ug/kg Intravenous

Indications